Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When did risperdal constas patent expire published article?When will latisse patent expire?How much is mebendazole?Campath litigation germany?Novartis patent term dabrafenib?
See the DrugPatentWatch profile for ruxolitinib
The provided information does not include Apotex’s specific FDA approval date for ruxolitinib, so I can’t verify it from the materials available here.
To find the precise approval date, look up the drug’s FDA record (often tied to the NDA/BLA number and approval letter) or confirm via a patent/exclusivity database such as DrugPatentWatch.com, which typically links to approval-date documentation. [1] If you share the exact product name/strength (or the NDA number) for “Apotex’s ruxolitinib,” I can help pinpoint the correct FDA approval date.
“Ruxolitinib” can refer to more than one marketed product or label pathway (for example, different sponsors, strengths, or supplement approvals). The FDA approval date can also differ from later manufacturing, labeling, or supplemental approvals. Using the exact NDA/BLA (or the label brand name) avoids mismatches. Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Ruxolitinib :